Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1904 of 6351
-
Arthritis drug shows promise for rare, Life-Threatening skin conditions
Disease control CompletedThe goal of this study is to evaluate the effect of tofacitinib in patients with Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The primary outcome of the study is the time to complete re-epithelialization. The secondary outcomes are to determine mortality, …
Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:13 UTC
-
New study probes hidden mental health links in kids who attempt suicide
Knowledge-focused Recruiting nowSeveral studies agree on the increase in suicide attempts in children over the past 15 years. This trend has been aggravated by the COVID 19 pandemic. It is recognized that suicide attempts are mostly encountered in individuals with a psychiatric disorder. Serious suicide attemp…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:47 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control OngoingA Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the maximum tolerated dose and recommended Phase II dose of HBI-2438 and characterize its pharmacokinetic profile.
Phase 1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Two drugs better than one for kids with high blood pressure in lungs?
Disease control CompletedThe investigators' central hypothesis is that early combination therapy with two PAH-specific oral therapies that have been shown to be well tolerated in the pediatric population, sildenafil and bosentan, will result in better World Health Organization (WHO) functional class at 1…
Phase 3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Ear stimulation helps babies avoid feeding tubes
Disease control CompletedFeeding is critical for pre-term infants and term infants with hypoxic ischemic brain injury, in order to be discharged home with their families and avoid a gastrostomy tube (G-tube) placement. The proposed study will employ a novel system that stimulates the vagus nerve through …
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New diabetes drug shows promise for early treatment
Disease control OngoingThis study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing treatment options when treatment is initiated early.
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a neck injection quiet the Brain's fear response in PTSD?
Symptom relief OngoingThis study will enroll patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for post-traumatic stress disorder (PTSD). Following an initial screening visit, clinical assessment, and enrollment, subjects will be randomized into tre…
Phase 4 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a quick artery fix replace daily pills for this blood pressure condition?
Disease control Recruiting nowIdiopathic hyperaldosteronism (IHA) represents about 65% of primary hyperaldosteronism cases. Although mineralocorticoid receptor antagonists (MRAs) are the standard first-line treatment, they are often limited by adverse effects. Superselective adrenal artery embolization (SAAE)…
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
AI-Powered camera spots seizures without wires
Diagnosis CompletedNelli is a video-based non-EEG physiological seizure monitoring system. This study is a blinded comparison of Nelli's identified events to gold-standard video EEG review in at-rest pediatric subjects with suspected motor seizures.
Sponsor: Neuro Event Labs Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Can oxygen during exercise supercharge lung rehab for ILD patients?
Symptom relief CompletedAlthough uncommon, interstitial lung diseases (ILDs), and particularly idiopathic pulmonary fibrosis (IPF), are progressive, irreversible, and ultimately fatal without treatment. Pharmacological therapies can slow the decline in forced vital capacity (FVC) and six-minute walk dis…
Sponsor: Frédéric Hérengt • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Scientists create detailed brain maps to protect language during surgery
Knowledge-focused Recruiting nowThe purpose of this study is to compare organization of normal brain function as detected using Functional magnetic resonance imaging (fMRI) in normal subjects as opposed to patients with epilepsy or brain tumors, to ascribe precise anatomic labels (including Brodmann Areas) and …
Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Could a simple home blood test spot lung cancer earlier?
Diagnosis Recruiting nowThis clinical trial investigates how practical and doable (feasibility) cell-free deoxyribonucleic acid (DNA) liquid biopsy is in screening high-risk patients for lung cancer. Currently, a low dose computed tomography (CT) scan is used to screen for lung cancer, however, due to v…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New hope for colorectal cancer: amivantamab plus chemotherapy in clinical trial
Disease control Recruiting nowThe purpose of this study is to assess the anti-tumor activity of amivantamab as a monotherapy (Cohorts A, B, and C), to assess the recommended phase 2 combination dose (RP2CD) of amivantamab when added to SoC chemotherapy (Ph1b cohorts) and to characterize the safety of amivanta…
Phase 1/2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a diabetes drug tame chronic heart failure? a Real-World study investigates
Disease control CompletedThe primary objective of this study is to monitor the safety profile of Jardiance® in Korean patient with chronic heart failure (New York Heart Association (NYHA) class II-IV) in a routine clinical setting.
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Seeing the invisible: could live air quality displays spark healthier choices?
Knowledge-focused CompletedThe goal of this study is to examine what effect real-time feedback on particulate matter (PM) air pollution levels has on risk recognition and behavior. The hypothesis is that real-time exposure feedback will change perceptions of risk and increase behaviors that avoid exposure …
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New cocktail of drugs tested for tough esophageal cancer
Disease control CompletedThis is a phase I/II multicenter, open-label umbrella platform study that will evaluate the safety and efficacy of investigational agents with pembrolizumab, plus chemotherapy or lenvatinib, for the treatment of participants with advanced esophageal cancer who have failed 1 prior…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New Sjögren's drug shows promise in small study
Disease control CompletedThis study aims at elucidating the mechanism of action of ianalumab in salivary glands and explore relationships with clinical assessments
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New cocktail of drugs targets Tough-to-Treat lung cancer
Disease control OngoingThis phase I trial tests the safety, side effects, and best dose of tazemetostat in combination with topotecan and pembrolizumab in treating patients with small cell lung cancer that has come back after a period of improvement (recurrent). Tazemetostat may stop the growth of tumo…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could skipping radiation help elderly brain cancer patients live longer with fewer side effects?
Disease control Recruiting nowCurrently, the optimal treatment regimen for elderly Glioblastoma (GBM) patients with poor performance status (PS) is unknown. Based on data for elderly GBM patients and the limited data for patients with poor PS, hypofractionated RT or a short course of Temozolomide (TMZ) may pr…
Phase 2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Earpiece could cut morphine use for Opioid-Dependent newborns
Symptom relief OngoingThe objective of this study is to determine if tAN therapy can reduce the median number of days of oral morphine administered to an infant after start of treatment.
Sponsor: Spark Biomedical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC